...
首页> 外文期刊>Chimerism >Combined treatment with regulatory T cells and vascularized b marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning
【24h】

Combined treatment with regulatory T cells and vascularized b marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning

机译:与调节性T细胞和血管化的骨髓移植相结合的治疗产生混合的嵌合现象,并在不进行细胞还原性调节的情况下诱导供体对血管化复合同种异体移植物的特异性耐受

获取原文
获取原文并翻译 | 示例
           

摘要

We demonstrate herein that combination treatment with regulatory T cells (T _(regs)) and vascularized bone mar-row transplantation (VBMT) can achieve stable mixed chimerism and long-term transplantation tolerance to vascularized composite allografts (VCA) without requiring cytoreductive recipient conditioning in rats. An appreciable number of T_(regs)of recipient origin was shown at the interface between recipient and transplanted VCA tissues, implicating a significant role for T_(regs) in protecting VCA from rejection. This cytoreduction-free protocol using co-treatment with T_(regs) and VBMT warrants further investigation toward potential clinical application for VCA transplantation.
机译:我们在本文中证明与调节性T细胞(T_(regs))和血管化骨基质移植(VBMT)的组合治疗可以实现稳定的混合嵌合和对血管化复合同种异体移植物(VCA)的长期移植耐受性,而无需进行细胞还原受体调节在大鼠中。在受体和移植的VCA组织之间的界面处显示了相当数量的受体来源的T_(regs),暗示着T_(regs)在保护VCA免受排斥中起重要作用。这种与T_regs和VBMT共同治疗的无细胞减少方案值得对VCA移植的潜在临床应用进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号